Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Hypertension in Pregnancy
3.921
Zitationen
0
Autoren
2013
Jahr
Abstract
Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy Hypertension in Pregnancy was developed by the Task Force on Hypertension in Pregnancy: James M. Roberts, MD, Chair; Phyllis A. August, MD, MPH; George Bakris, MD; John R. Barton, MD; Ira M. Bernstein, MD; Maurice Druzin, MD; Robert R. Gaiser, MD; Joey R Granger, PhD; Arun Jeyabalan, MD, MS; Donna D. Johnson, MD; S. Ananth Karumanchi, MD; Marshall Lindheimer, MD; Michelle Y. Owens, MD, MS; George R. Saade, MD; Baha M. Sibai, MD; Catherine Y. Spong, MD; Eleni Tsigas; and the American College of Obstetricians and Gynecologists' staff: Gerald F. Joseph, MD; Nancy O'Reilly, MHS; Alyssa Politzer; Sarah Son, MPH; and Karina Ngaiza. The information in Hypertension in Pregnancy should not be viewed as a body of rigid rules. The guidelines are general and intended to be adapted to many different situations, taking into account the needs and resources particular to the locality, the institution, or the type of practice. Variations and innovations that improve the quality of patient care are to be encouraged rather than restricted. The purpose of these guidelines will be well served if they provide a firm basis on which local norms may be built.
Ähnliche Arbeiten
Hyperglycemia and Adverse Pregnancy Outcomes
2008 · 5.522 Zit.
International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
2010 · 5.352 Zit.
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 · 3.938 Zit.
Circulating Angiogenic Factors and the Risk of Preeclampsia
2004 · 3.560 Zit.
Fetal origins of coronary heart disease
1995 · 3.527 Zit.